Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials

PURPOSE: To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive generations of Stanford clinical trials. PATIENTS AND METHODS: Patients with HL treated at Stanford with at least 5 years of follow-up after...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Koontz, Michael Zach, Horning, Sandra J., Balise, Raymond, Greenberg, Peter L., Rosenberg, Saul A., Hoppe, Richard T., Advani, Ranjana H.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2013
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3565182/
https://ncbi.nlm.nih.gov/pubmed/23295809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.44.5791
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares